Search results for: 'rare computer hardware'

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

Computed tomography (CT) is a sophisticated imaging technology that combines X-ray measurements obtained from multiple angles and processes them using computer algorithms to generate cross-sectional images or tomograms. The tomograms are further reconstructed into a 3D representation of organs or tissues, allowing precise visualization of the inter...

06 Nov 2017  |  North America  |  Market Research

Global Computed Tomography Market, Forecast to 2021

With Minimal Technological Differentiation, Stake Holders Focus on Value Based Products and Operational Expenditure Models

Infographics

×

The study aims to analyze and forecast the Computed Tomography market in North America (the United States and Canada), Europe and Asia-Pacific countries for 2016. Research Scope: Market trends (Utilization of conventional and emerging clinical applications, growth indicators, factors influencing ROI, critical unmet needs and potential game changi...

Quantum computing technology is constantly evolving and finding applications across various sectors, including healthcare and security. This revolutionary technology holds immense potential to resolve complex computational tasks that current computing systems cannot address. Unlike classical computing systems, quantum computing is based on quantum ...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

This study examines the emerging landscape of neuromorphic computing and its role in enabling low-power, real-time, brain-inspired intelligence across edge and autonomous systems. It reviews advancements in spiking neural networks, memristor-based computing in memory, event-driven vision sensors, and hybrid neuromorphic and conventional architectur...

09 Nov 2022  |  Global  |  Technology Research

Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

Infographics

×

Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...